DPIs CONSIDERED MEDICALLY ACCEPTABLE ALTERNATIVE TO CFC PRODUCTS, FDA ADVISORY CMTE. SAYS; POTENCIES OF CFC-FREE AND CFC PRODUCTS SHOULD BE COMPARED
Executive Summary
Dry powder inhalers are a technically and medically feasible alternative to CFC-containing metered dose inhalers, FDA's Pulmonary-Allergy Drugs Advisory Committee concluded at its April 11 meeting. "What we are hearing...is that people feel that there is a role for DPIs, and with most patients they could be a substitute," summarized Committee Chairperson Shirley Murphy, MD, University of New Mexico.